Bayer achieved its 2010 financial targets with record sales of €35.1 billion and adjusted EBITDA of €7.1 billion. However, earnings were diminished by €1.7 billion in special charges. Q4 2010 sales grew 8% year-over-year while adjusted EBITDA rose 12%, though reported EBIT declined 86% due to special charges. Bayer expects 2011 core EPS to increase around 10% and adjusted EBITDA and sales to grow by 10% and 5% respectively.